PMV Pharmaceuticals Statistics

Total Valuation

PMVP has a market cap or net worth of $55.59 million. The enterprise value is -$109.13 million.

Market Cap	55.59M
Enterprise Value	-109.13M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

PMVP has 51.95 million shares outstanding. The number of shares has increased by 4.60% in one year.

Current Share Class	51.95M
Shares Outstanding	51.95M
Shares Change (YoY)	+4.60%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	3.10%
Owned by Institutions (%)	38.80%
Float	33.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.35
P/TBV Ratio	0.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.75, with a Debt / Equity ratio of 0.01.

Current Ratio	16.75
Quick Ratio	16.43
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.66% and return on invested capital (ROIC) is -28.69%.

Return on Equity (ROE)	-32.66%
Return on Assets (ROA)	-27.24%
Return on Invested Capital (ROIC)	-28.69%
Return on Capital Employed (ROCE)	-55.20%
Revenue Per Employee	n/a
Profits Per Employee	-$1.30M
Employee Count	47
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-18.30M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.54% in the last 52 weeks. The beta is 1.43, so PMVP's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	-35.54%
50-Day Moving Average	0.98
200-Day Moving Average	1.33
Relative Strength Index (RSI)	54.21
Average Volume (20 Days)	283,238

Short Selling Information

The latest short interest is 868,726, so 1.67% of the outstanding shares have been sold short.

Short Interest	868,726
Short Previous Month	854,290
Short % of Shares Out	1.67%
Short % of Float	2.63%
Short Ratio (days to cover)	2.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-88.79M
Pretax Income	-65.05M
Net Income	-60.88M
EBITDA	-87.98M
EBIT	-88.79M
Earnings Per Share (EPS)	-$1.18

Full Income Statement

Balance Sheet

The company has $160.39 million in cash and $1.11 million in debt, giving a net cash position of $164.72 million or $3.17 per share.

Cash & Cash Equivalents	160.39M
Total Debt	1.11M
Net Cash	164.72M
Net Cash Per Share	$3.17
Equity (Book Value)	160.11M
Book Value Per Share	3.08
Working Capital	153.74M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.36 million and capital expenditures -$65,000, giving a free cash flow of -$53.43 million.

Operating Cash Flow	-53.36M
Capital Expenditures	-65,000
Free Cash Flow	-53.43M
FCF Per Share	-$1.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PMVP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.60%
Shareholder Yield	-4.60%
Earnings Yield	-109.51%
FCF Yield	-96.11%

Analyst Forecast

The average price target for PMVP is $5.00, which is 367.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.00
Price Target Difference	367.29%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.61%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1